REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 83 filers reported holding REVANCE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.20 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $190,242 | -53.9% | 16,586 | +1.8% | 0.00% | 0.0% |
| Q2 2023 | $412,249 | -16.0% | 16,288 | +6.9% | 0.00% | -50.0% |
| Q1 2023 | $490,977 | +54.7% | 15,243 | -11.3% | 0.00% | +100.0% |
| Q4 2022 | $317,383 | -16.3% | 17,193 | +22.3% | 0.00% | 0.0% |
| Q3 2022 | $379,000 | +102.7% | 14,057 | +3.8% | 0.00% | 0.0% |
| Q2 2022 | $187,000 | -53.2% | 13,541 | -34.1% | 0.00% | 0.0% |
| Q1 2022 | $400,000 | -3.4% | 20,556 | -19.2% | 0.00% | 0.0% |
| Q4 2021 | $414,000 | -38.9% | 25,425 | +4.5% | 0.00% | -50.0% |
| Q3 2021 | $678,000 | -26.4% | 24,340 | -21.6% | 0.00% | -33.3% |
| Q2 2021 | $921,000 | +23.5% | 31,062 | +16.4% | 0.00% | +50.0% |
| Q1 2021 | $746,000 | +8.7% | 26,677 | +10.2% | 0.00% | -33.3% |
| Q4 2020 | $686,000 | +48.8% | 24,210 | +32.0% | 0.00% | +50.0% |
| Q3 2020 | $461,000 | +12.2% | 18,338 | +8.9% | 0.00% | 0.0% |
| Q2 2020 | $411,000 | +174.0% | 16,834 | +66.3% | 0.00% | +100.0% |
| Q1 2020 | $150,000 | -41.9% | 10,122 | -36.2% | 0.00% | 0.0% |
| Q4 2019 | $258,000 | +17.3% | 15,873 | -6.4% | 0.00% | 0.0% |
| Q3 2019 | $220,000 | +0.5% | 16,954 | +0.3% | 0.00% | 0.0% |
| Q2 2019 | $219,000 | -27.2% | 16,895 | -11.6% | 0.00% | -50.0% |
| Q1 2019 | $301,000 | -6.5% | 19,114 | +19.5% | 0.00% | 0.0% |
| Q4 2018 | $322,000 | -32.1% | 15,994 | -16.2% | 0.00% | -33.3% |
| Q3 2018 | $474,000 | -12.7% | 19,078 | -3.6% | 0.00% | -25.0% |
| Q2 2018 | $543,000 | -13.1% | 19,781 | -2.6% | 0.00% | 0.0% |
| Q1 2018 | $625,000 | -12.8% | 20,307 | +1.2% | 0.00% | -20.0% |
| Q4 2017 | $717,000 | +37.6% | 20,069 | +6.2% | 0.01% | 0.0% |
| Q3 2017 | $521,000 | +12.5% | 18,898 | +7.9% | 0.01% | 0.0% |
| Q2 2017 | $463,000 | +23.8% | 17,521 | -2.7% | 0.01% | +25.0% |
| Q1 2017 | $374,000 | -18.3% | 18,003 | -18.6% | 0.00% | -20.0% |
| Q4 2016 | $458,000 | +41.4% | 22,124 | +10.7% | 0.01% | 0.0% |
| Q3 2016 | $324,000 | +0.6% | 19,985 | -15.6% | 0.01% | +25.0% |
| Q2 2016 | $322,000 | -19.9% | 23,688 | +2.9% | 0.00% | -33.3% |
| Q1 2016 | $402,000 | -53.4% | 23,018 | -8.8% | 0.01% | -40.0% |
| Q4 2015 | $862,000 | +46.6% | 25,236 | +27.7% | 0.01% | +25.0% |
| Q3 2015 | $588,000 | -12.9% | 19,762 | -6.4% | 0.01% | -11.1% |
| Q2 2015 | $675,000 | +56.6% | 21,106 | +1.6% | 0.01% | +80.0% |
| Q1 2015 | $431,000 | +45.1% | 20,775 | +18.4% | 0.01% | +66.7% |
| Q4 2014 | $297,000 | – | 17,544 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,415,689 | $86,106,000 | 6.66% |
| Evolutionary Tree Capital Management, LLC | 176,336 | $3,439,000 | 2.39% |
| Essex Woodlands Management, Inc. | 457,085 | $8,913,000 | 2.16% |
| HealthCor Management, L.P. | 1,423,425 | $27,757,000 | 1.85% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,112,325 | $21,690,000 | 0.86% |
| Waypoint Capital Advisors, LLC | 53,989 | $1,016,000 | 0.60% |
| Antara Capital LP | 679,600 | $13,252,000 | 0.40% |
| Rhenman & Partners Asset Management AB | 198,358 | $3,868,000 | 0.38% |
| Walleye Capital LLC | 505,701 | $9,861,000 | 0.26% |
| Polar Capital Holdings Plc | 2,456,497 | $47,902,000 | 0.22% |